-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Finishing: Cypress Blue - Pharmacy Manager Recently, according to the results of adverse drug reaction assessment, in order to further protect the public drug safety, the State Administration of Supervision on Ginkgo leaves, Ginkgo biloba capsules, ginkgo biloba soft capsules, ginkgo biloba particles, ginkgo biloba, ginkgo biloba, Ginkgo dippers, Ginkgo tea particles 8 Ginkgo dips oral solid preparations, ginkgo apricot, ginkgo apricot 3 liquid preparations, Ginkgo tether, Ginkgo tether dispersal tablets, ginkgo ketone droplets, ginkgo ketone esters capsules, ginkgo ketone esters, ginkgo ketone saline particles, apricot dispersal tablets, apricot droppills 7 Ginkgo ketone oral preparation drug specifications (adverse reactions, taboos), precautions.
Ginkgo leaves, Ginkgo biloba capsules, ginkgo biloba, Ginkgo biloba, ginkgo biloba droplets, ginkgo tea particles 8 Ginkgo biloba oral solid preparation specification revision requirements 1, "adverse reactions" should be increased: after the market adverse reaction monitoring data show that the following adverse reactions to oral preparations such as ginkgo biloba: gastrointestinal system, vomiting, abdominal pain, abdominal swelling, abdominal swelling, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain,
nervous system: dizziness, headache, etc., there are local cases of numbness reported.
skin and its accessories: rash, itching, etc.
cardiovascular system: chest tightness, palpitations, etc., there are reports of elevated or lowered blood pressure.
other: fatigue, allergy or allergic reactions, there are reports of gum bleeding, nosebleeds and other cases.
. 2. Taboo s. items should be added: "Prohibited for all allergies to this product and the ingredients contained in it."
. 3. The items should be added: (1) heart failure, pregnant women and allergy patients with caution; (2) in strict accordance with the instructions for use, need long-term medication, should be used under the guidance of a doctor; (3) for patients who have a tendency to bleed or use anticoagulant, anti-platelet treatment, should use this product under the guidance of a doctor; (4) the preparation containing ginkgo leaves may increase the risk of bleeding during the surgery period.
Ginkgo biloba, ginkgo biloba drops, Ginkgo biloba oral solution 3 liquid preparation specification revision requirements 1, "adverse reactions" item should be increased: after the market adverse reaction monitoring data show that the following adverse reactions can be seen in the oral preparations of Ginkgo biloba: gastrointestinal system: nausea, vomiting, dry mouth, bloating, abdominal pain, abdominal discomfort, excessive acid, etc., there are cases of digestive bleeding reported.
nervous system: dizziness, headache, etc., there are local cases of numbness reported.
skin and its accessories: rash, itching, etc.
cardiovascular system: chest tightness, palpitations, etc., there are reports of elevated or lowered blood pressure.
other: fatigue, allergy or allergic reactions, there are reports of gum bleeding, nosebleeds and other cases.
. 2. Taboo s. items should be added: "Prohibited for all allergies to this product and the ingredients contained in it."
3. Notes should be added: (1) heart failure, pregnant women and allergy patients with caution; (2) use strictly in accordance with the instructions for use, need long-term medication, should be used under the guidance of a doctor; (3) for patients who have a tendency to bleed or use anticoagulant, anti-platelet treatment, should use this product under the guidance of a doctor; (5) This product contains alcohol, alcohol-related dangerous diseases or individuals (such as liver disease patients, alcoholic cardiomyopathy, drivers, high-altitude operators, etc.) should be banned or used with caution; cephalosporine, lacoxey cephalosporine, chloramphenicol, chlorosulphate, Glebeluen, Greblyone, toluene, aflatoxin, 5-nitroquine, ketoconazole, propylene, central nervous system inhibitors, etc.
Ginkgo ketone ester dispersion tablets, ginkgo ketone ester drops, ginkgo ketone ester capsules, ginkgo ketone tablets, apricot dispersal tablets, apricot drop pills 7 Ginkgo ketone esters oral preparation specification revision requirements 1, "adverse reactions" items should be increased: after the market adverse reaction monitoring data show that the following adverse reactions are visible: gastrointestinal system, vomiting, abdominal abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain, abdominal pain,
nervous system: dizziness, headache, etc.
skin and its accessories: rash, itching, etc.
cardiovascular system: chest tightness, palpitations, etc.
other: fatigue, allergies, or allergic reactions, etc.
. 2. Taboo s. items should be added: "Prohibited for all allergies to this product and the ingredients contained in it."
. 3. The items should be added: (1) heart failure, pregnant women and allergy patients with caution; (2) in strict accordance with the instructions for use, need long-term medication, should be used under the guidance of a doctor; (3) for patients who have a tendency to bleed or use anticoagulant, anti-platelet treatment, should use this product under the guidance of a doctor; (4) the preparation containing ginkgo leaves may increase the risk of bleeding during the surgery period.
in addition, the State Drug Administration at the same time issued the "State Drug Administration on the revision of the Huayu re-product pill instructions", pregnant women banned.
The revised requirements of the specification of Huayu Remanufactured Pills I, "Adverse Reactions" should be increased: After the market monitoring data show that the following adverse reactions can be seen in this product: gastrointestinal system: nausea, vomiting, abdominal pain, bloating, diarrhea, constipation, dry mouth, mouth pain, heartburn, acid and so on.
nervous system: dizziness, headache, etc., there are cases of limb numbness, tongue numbness.
cardiovascular system: chest tightness, palpitations, etc.
skin: rash, itching, etc.
other: fever, shortness of breath, abnormal liver function, abnormal renal function case report.
2, "Taboo" should be added: 1. For this product and ingredient allergy is prohibited.
2. Pregnant women are prohibited.
, "Precautions" should be added: 1. This product should be used in accordance with the drug specifications , "usage" provisions, not excessive, long-term drug use.
2. Use with caution in people with abnormal liver and kidney function.
remove the "3, commonly used quantity: 8g (g) each time (about 48 to 50 pills), morning and evening each take 1 time.
10 days, stop the drug for 1 day, 30 days for a course of treatment, can be connected to 3 courses.
prevention and maintenance of 4g (g) each time, morning and evening each serve 1 time.
"